Epitomics will use its RabMAb technology to produce antibodies for use in Bayer's drug target identification and validation

Epitomics Inc.

U.S. / Tools, Services, and Manufacturing

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Bayer AG

Germany / Large-Cap Biopharma (>=$50 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced